Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

6.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.3K
Transducer Mechanism: G Protein–Coupled Receptors01:30

Transducer Mechanism: G Protein–Coupled Receptors

3.1K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Residue-level insights into SGLT2 inhibition and Nav1.5 selectivity of gliflozin derivatives: A molecular dynamics and pharmacophore-guided study.

Journal of molecular graphics & modelling·2026
Same author

AI-MedCraft: A Strategy-Driven AI Platform for Multi-Objective Molecular Design.

Journal of chemical information and modeling·2026
Same author

Multiscale computational analysis reveals enhanced allosteric modulation of Nav1.5 by dual binding of dapagliflozin and ertugliflozin.

Scientific reports·2025
Same author

The relationship between COVID-19 and opioid-related emergency department visits in Alberta, Canada: an interrupted time series analysis.

Health promotion and chronic disease prevention in Canada : research, policy and practice·2025
Same author

P4ward: An Automated Modeling Platform for Protac Ternary Complexes.

Journal of chemical information and modeling·2025
Same author

Therapeutic potential of TIM-3 inhibition in cancer, viral infections, and autoimmune disorders.

The international journal of biochemistry & cell biology·2025

Related Experiment Video

Updated: Nov 6, 2025

Capture Compound Mass Spectrometry - A Powerful Tool to Identify Novel c-di-GMP Effector Proteins
12:11

Capture Compound Mass Spectrometry - A Powerful Tool to Identify Novel c-di-GMP Effector Proteins

Published on: March 29, 2015

11.9K

GPCR_LigandClassify.py; a rigorous machine learning classifier for GPCR targeting compounds.

Marawan Ahmed1, Horia Jalily Hasani1, Subha Kalyaanamoorthy1,2

  • 1Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, 116 Street & 85 Avenue, Edmonton, AB, T6G 2R3, Canada.

Scientific Reports
|May 5, 2021
PubMed
Summary

Machine learning models were built for drug repurposing against G-Protein Coupled Receptors (GPCRs). These models achieved ~90% accuracy, identifying potential new uses for existing drugs.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.8K

Related Experiment Videos

Last Updated: Nov 6, 2025

Capture Compound Mass Spectrometry - A Powerful Tool to Identify Novel c-di-GMP Effector Proteins
12:11

Capture Compound Mass Spectrometry - A Powerful Tool to Identify Novel c-di-GMP Effector Proteins

Published on: March 29, 2015

11.9K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.8K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.8K

Area of Science:

  • Computational chemistry
  • Pharmacology
  • Machine learning

Background:

  • G-Protein Coupled Receptors (GPCRs) are a major drug target family.
  • Drug repurposing offers a faster route to new therapeutics.
  • Developing accurate predictive models for GPCR-ligand interactions is crucial.

Purpose of the Study:

  • To construct and evaluate ligand-based machine learning models for drug repurposing against GPCRs.
  • To compare the performance of various machine learning algorithms and featurization methods.
  • To identify novel drug-GPCR associations.

Main Methods:

  • Collected over 500,000 data points from the GPCR-Ligand Association (GLASS) database.
  • Employed diverse molecular featurization techniques.
  • Developed and compared supervised machine learning algorithms, including ensemble decision trees, gradient boosted trees, and deep neural networks (DNNs).

Main Results:

  • Machine learning models, particularly ensemble and gradient boosted trees with molecular fingerprinting, demonstrated performance comparable to DNNs.
  • Models achieved approximately 90% classification accuracy on a test dataset.
  • Identified potential drug-GPCR associations, aligning with existing literature.

Conclusions:

  • Ligand-based machine learning models are effective tools for GPCR drug repurposing.
  • Ensemble and gradient boosted trees offer a competitive alternative to DNNs for this task.
  • The developed models can accelerate computational drug discovery and identify novel therapeutic applications.